SandboxAQ and Mayo Clinic Collaboration Highlights:
– SandboxAQ and Mayo Clinic are partnering to explore the use of ECG and MCG with a quantum-based sensor for monitoring amyloidosis.
– Amyloidosis is a condition marked by abnormal protein accumulation in organs, including the heart.
– The goal of the collaboration is to create a non-invasive method for monitoring cardiovascular health in amyloidosis patients.
Author’s Take:
The partnership between SandboxAQ and Mayo Clinic to advance cardiovascular disease monitoring in amyloidosis through innovative technology showcases the power of collaboration between industry leaders and healthcare institutions. This joint effort opens up possibilities for non-invasive monitoring techniques, potentially revolutionizing the way patients with amyloidosis are cared for.
Click here for the original article.